Crocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK

Li,Kang; Li,Yan; Ma,Zhenjiang; Zhao,Jie

doi:10.3892/ijmm.2015.2359

Crocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK

Authors:
- Kang Li
- Yan Li
- Zhenjiang Ma
- Jie Zhao
View Affiliations

Affiliations: Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China
Published online on: September 30, 2015 https://doi.org/10.3892/ijmm.2015.2359
Pages: 1291-1299
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As intervertebral disc (IVD) degeneration has been proven to contribute to low back pain (LBP), drug treatment aiming at attenuating IVD degeneration may prove to be benefiical. Crocin, a bioactive component of saffron, has been found to exert anti-inflammatory effects on cartilage. In the present study, the anti-inflammatory and anti-catabolic effects of crocin on rat IVDs were analyzed in vitro and ex vivo. Nucleus pulposus (NP) cells were isolated from the lumbar IVDs of Sprague-Dawley rats. The NP cells were first treated with various concentrations of crocin, and then stimulated with lipopolysaccharide (LPS) to induce inflammation. Subsequently, RT-qPCR and enzyme-linked immunosorbent assay were carried out to measure the expression levels of catabolic enzymes, pro-inflammatory factors and the components of the extracellular matrix (ECM). In addition, western blot analysis was also used to investigate the related signaling pathways. The whole spinal motion segment (vertebra-IVD-vertebra section) of the rats was isolated and cultured in the presence or absence of LPS and crocin for 7 days. The ex vivo effects of crocin on the ECM of the IVD structures were determined by histological and biochemical analysis. In vitro, crocin significantly inhibited the LPS-induced overexpression of catabolic enzymes [matrix metalloproteinase (MMP)-1, MMP-3, MMP-13, a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif (ADAMTS)-4 and ADAMTS‑5], pro-inflammatory factors [interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 and inducible nitric oxide synthase (iNOS)] and Toll-like receptor (TLR)‑2 in a concentration-dependent manner. Notably, crocin partly prevented the downregulation of aggrecan and type II collagen (collagen‑II). Moreover, crocin suppressed the LPS-induced activation of the mitogen-activated protein kinase (MAPK) pathway by inhibiting the phosphorylation of c-Jun N-terminal kinase (JNK). Ex vivo experiments demonstrated that crocin protected the rat IVDs from the LPS-induced depletion of the ECM components, including proteoglycan and collagen-II. In conclusion, crocin effectively suppressed the degeneration-related inflammation and catabolism in rat IVDs in vitro and ex vivo, suggesting that crocin has potential for use as a therapuetic strategy in the treatment of LBP.

View Figures

View References

1	Hart LG, Deyo RA and Cherkin DC: Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine. 20:11–19. 1995. View Article : Google Scholar : PubMed/NCBI
2	Katz JN: Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am. 88(Suppl 2): 21–24. 2006. View Article : Google Scholar : PubMed/NCBI
3	Kuslich SD, Ulstrom CL and Michael CJ: The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am. 22:181–187. 1991.PubMed/NCBI
4	Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G and Bogduk N: The relative contributions of the disc and zygapophyseal joint in chronic low back pain. Spine. 19:801–806. 1994. View Article : Google Scholar : PubMed/NCBI
5	Nerlich AG, Schleicher ED and Boos N: 1997 Volvo Award winner in basic science studies. Immunohistologic markers for age-related changes of human lumbar intervertebral discs. Spine. 22:2781–2795. 1997. View Article : Google Scholar
6	Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF and Nerlich AG: Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine. 27:2631–2644. 2002. View Article : Google Scholar : PubMed/NCBI
7	Bibby SR, Jones DA, Lee RB, Yu J and Urban JPG: The pathophysiology of the intervertebral disc. Joint Bone Spine. 68:537–542. 2001. View Article : Google Scholar
8	Urban JP and Roberts S: Degeneration of the intervertebral disc. Arthritis Res Ther. 5:120–130. 2003. View Article : Google Scholar : PubMed/NCBI
9	Roberts S, Evans H, Trivedi J and Menage J: Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am. 88(Suppl 2): 10–14. 2006. View Article : Google Scholar : PubMed/NCBI
10	Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ and Hoyland JA: Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 35:652–655. 2007. View Article : Google Scholar : PubMed/NCBI
11	Zhao CQ, Wang LM, Jiang LS and Dai LY: The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev. 6:247–261. 2007. View Article : Google Scholar : PubMed/NCBI
12	Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M and Boos N: Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann NY Acad Sci. 1096:44–54. 2007. View Article : Google Scholar : PubMed/NCBI
13	Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, Bullock R, Isaacs RE, Brown C and Richardson WJ: Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 62:1974–1982. 2010.PubMed/NCBI
14	Weiler C, Nerlich AG, Bachmeier BE and Boos N: Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine. 30:44–53; discussion 54. 2005.PubMed/NCBI
15	Burke JG, Watson RW, McCormack D, Dowling FE, Walsh MG and Fitzpatrick JM: Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 84:196–201. 2002. View Article : Google Scholar : PubMed/NCBI
16	Liu MH, Sun JS, Tsai SW, Sheu SY and Chen MH: Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation. Nutr Res. 30:57–65. 2010. View Article : Google Scholar : PubMed/NCBI
17	Kim KW, Chung HN, Ha KY, Lee JS and Kim YY: Senescence mechanisms of nucleus pulposus chondrocytes in human intervertebral discs. Spine J. 9:658–666. 2009. View Article : Google Scholar : PubMed/NCBI
18	Huang QQ and Pope RM: The role of toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep. 11:357–364. 2009. View Article : Google Scholar : PubMed/NCBI
19	Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, Popa C, van der Meer JW, Netea MG and van den Berg WB: Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56:2957–2967. 2007. View Article : Google Scholar : PubMed/NCBI
20	Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, Weichhart T, Saemann M and Smolen JS: Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum. 56:1880–1893. 2007. View Article : Google Scholar : PubMed/NCBI
21	Iacono A, Gómez R, Sperry J, Conde J, Bianco G, Meli R, Gómez-Reino JJ, Smith AB III and Gualillo O: Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum. 62:1675–1682. 2010. View Article : Google Scholar : PubMed/NCBI
22	Pålsson-McDermott EM and O'Neill LA: Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology. 113:153–162. 2004. View Article : Google Scholar : PubMed/NCBI
23	Jasin HE: Bacterial lipopolysaccharides induce in vitro degradation of cartilage matrix through chondrocyte activation. J Clin Invest. 72:2014–2019. 1983. View Article : Google Scholar : PubMed/NCBI
24	Kittlick PD and Engelmann D: Effect of the microbial constituents, LPS and BCG, on the glycosaminoglycans of chondrocyte cultures. Exp Pathol. 42:145–150. 1991. View Article : Google Scholar : PubMed/NCBI
25	Berenbaum F: Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol. 16:616–622. 2004. View Article : Google Scholar : PubMed/NCBI
26	Avruch J: MAP kinase pathways: the first twenty years. Biochim Biophys Acta. 1773:1150–1160. 2007. View Article : Google Scholar : PubMed/NCBI
27	Chung JW, Zeng Y and Wong TK: Drug therapy for the treatment of chronic nonspecific low back pain: systematic review and meta-analysis. Pain Physician. 16:E685–E704. 2013.PubMed/NCBI
28	Michaleff ZA, Kamper SJ, Maher CG, Evans R, Broderick C and Henschke N: Low back pain in children and adolescents: a systematic review and meta-analysis evaluating the effectiveness of conservative interventions. Eur Spine J. 23:2046–2058. 2014. View Article : Google Scholar : PubMed/NCBI
29	Phillips FM, Slosar PJ, Youssef JA, Andersson G and Papatheofanis F: Lumbar spine fusion for chronic low back pain due to degenerative disc disease: a systematic review. Spine (Phila Pa 1976). 38:E409–E422. 2013. View Article : Google Scholar
30	Xu GL, Li G, Ma HP, Zhong H, Liu F and Ao GZ: Preventive effect of crocin in inflamed animals and in LPS-challenged RAW 264.7 cells. J Agric Food Chem. 57:8325–8330. 2009. View Article : Google Scholar : PubMed/NCBI
31	Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, Jung WS, Cho KH, Park JH, Kang I, et al: Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol. 648:110–116. 2010. View Article : Google Scholar : PubMed/NCBI
32	Kim JH, Park GY, Bang SY, Park SY, Bae SK and Kim Y: Crocin suppresses LPS-stimulated expression of inducible nitric oxide synthase by upregulation of heme oxygenase-1 via calcium/calmodulin-dependent protein kinase 4. Mediators Inflamm. 2014(728709)2014. View Article : Google Scholar
33	Ding Q, Zhong H, Qi Y, Cheng Y, Li W, Yan S and Wang X: Anti-arthritic effects of crocin in interleukin-1β-treated articular chondrocytes and cartilage in a rabbit osteoarthritic model. Inflamm Res. 62:17–25. 2013. View Article : Google Scholar
34	Risbud MV, Izzo MW, Adams CS, Arnold WW, Hillibrand AS, Vresilovic EJ, Vaccaro AR, Albert TJ and Shapiro IM: An organ culture system for the study of the nucleus pulposus: description of the system and evaluation of the cells. Spine. 28:2652–2658; discussion 2658–2659. 2003. View Article : Google Scholar : PubMed/NCBI
35	Ponnappan RK, Markova DZ, Antonio PJ, Murray HB, Vaccaro AR, Shapiro IM, Anderson DG, Albert TJ and Risbud MV: An organ culture system to model early degenerative changes of the intervertebral disc. Arthritis Res Ther. 13. pp. R1712011, View Article : Google Scholar
36	Lim TH, Ramakrishnan PS, Kurriger GL, Martin JA, Stevens JW, Kim J and Mendoza SA: Rat spinal motion segment in organ culture: a cell viability study. Spine. 31:1291–1297; discussion 1298. 2006. View Article : Google Scholar : PubMed/NCBI
37	Chiba K, Andersson GB, Masuda K, Momohara S, Williams JM and Thonar EJ: A new culture system to study the metabolism of the intervertebral disc in vitro. Spine. 23:1821–1827; discussion 1828. 1998. View Article : Google Scholar : PubMed/NCBI
38	Chandrasekhar S, Esterman MA and Hoffman HA: Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem. 161:103–108. 1987. View Article : Google Scholar : PubMed/NCBI
39	Studer RK, Aboka AM, Gilbertson LG, Georgescu H, Sowa G, Vo N and Kang JD: p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration. Spine (Phila Pa 1976). 32:2827–2833. 2007. View Article : Google Scholar
40	Kim JH, Studer RK, Vo NV, Sowa GA and Kang JD: p38 MAPK inhibition selectively mitigates inflammatory mediators and VEGF production in AF cells co-cultured with activated macrophage-like THP-1 cells. Osteoarthritis Cartilage. 17:1662–1669. 2009. View Article : Google Scholar : PubMed/NCBI
41	Wuertz K, Vo N, Kletsas D and Boos N: Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-κB and MAP kinases. Eur Cell Mater. 23:103–120. 2012.
42	Alavizadeh SH and Hosseinzadeh H: Bioactivity assessment and toxicity of crocin: A comprehensive review. Food Chem Toxicol. 64:65–80. 2014. View Article : Google Scholar
43	Aota Y, An HS, Imai Y, Thonar EJ, Muehleman C and Masuda K: Comparison of cellular response in bovine intervertebral disc cells and articular chondrocytes: effects of lipopolysaccharide on proteoglycan metabolism. Cell Tissue Res. 326:787–793. 2006. View Article : Google Scholar : PubMed/NCBI
44	Ellman MB, Kim JS, An HS, Chen D, Kc R, An J, Dittakavi T, van Wijnen AJ, Cs-Szabo G, Li X, et al: Toll-like receptor adaptor signaling molecule MyD88 on intervertebral disk homeostasis: In vitro, ex vivo studies. Gene. 505:283–290. 2012. View Article : Google Scholar : PubMed/NCBI
45	Iwata M, Ochi H, Asou Y, Haro H, Aikawa T, Harada Y, Nezu Y, Yogo T, Tagawa M and Hara Y: Variations in gene and protein expression in canine chondrodystrophic nucleus pulposus cells following long-term three-dimensional culture. PLoS One. 8:e631202013. View Article : Google Scholar : PubMed/NCBI
46	Kim JS, Ellman MB, Yan D, An HS, Kc R, Li X, Chen D, Xiao G, Cs-Szabo G, Hoskin DW, et al: Lactoferricin mediates anti-inflammatory and anti-catabolic effects via inhibition of IL-1 and LPS activity in the intervertebral disc. J Cell Physiol. 228:1884–1896. 2013. View Article : Google Scholar : PubMed/NCBI
47	Rajan NE, Bloom O, Maidhof R, Stetson N, Sherry B, Levine M and Chahine NO: Toll-Like Receptor 4 (TLR4) expression and stimulation in a model of intervertebral disc inflammation and degeneration. Spine. 38:1343–1351. 2013. View Article : Google Scholar
48	Takaishi H, Kimura T, Dalal S, Okada Y and D'Armiento J: Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol. 9:47–54. 2008. View Article : Google Scholar : PubMed/NCBI
49	Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G and Hamilton JA: The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem. 267:19470–19474. 1992.PubMed/NCBI
50	Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, et al: Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science. 284:1664–1666. 1999. View Article : Google Scholar : PubMed/NCBI
51	Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, Ellis DM, Tortorella MD, Pratta MA, Hollis JM, et al: Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem. 274:23443–23450. 1999. View Article : Google Scholar : PubMed/NCBI
52	Yu ZG, Xu N, Wang WB, Pan SH, Li KS and Liu JK: Interleukin-1 inhibits Sox9 and collagen type II expression via nuclear factor-kappaB in the cultured human intervertebral disc cells. Chin Med J (Engl). 122:2483–2488. 2009.
53	Akyol S, Eraslan BS, Etyemez H, Tanriverdi T and Hanci M: Catabolic cytokine expressions in patients with degenerative disc disease. Turk Neurosurg. 20:492–499. 2010.PubMed/NCBI
54	Lee S, Moon CS, Sul D, Lee J, Bae M, Hong Y, Lee M, Choi S, Derby R, Kim BJ, et al: Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem. 42:1504–1511. 2009. View Article : Google Scholar : PubMed/NCBI
55	Sinclair SM, Shamji MF, Chen J, Jing L, Richardson WJ, Brown CR, Fitch RD and Setton LA: Attenuation of inflammatory events in human intervertebral disc cells with a tumor necrosis factor antagonist. Spine. 36:1190–1196. 2011. View Article : Google Scholar : PubMed/NCBI
56	Studer RK, Vo N, Sowa G, Ondeck C and Kang J: Human nucleus pulposus cells react to IL-6: independent actions and amplification of response to IL-1 and TNF-α. Spine. 36:593–599. 2011. View Article : Google Scholar
57	Furusawa N, Baba H, Miyoshi N, Maezawa Y, Uchida K, Kokubo Y and Fukuda M: Herniation of cervical intervertebral disc: immunohistochemical examination and measurement of nitric oxide production. Spine. 26:1110–1116. 2001. View Article : Google Scholar : PubMed/NCBI
58	Takeda K and Akira S: Toll-like receptors in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar
59	O'Neill LA and Dinarello CA: The IL-1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense. Immunol Today. 21:206–209. 2000. View Article : Google Scholar : PubMed/NCBI
60	Joosten LA, Koenders MI, Smeets RL, Heuvelmans-Jacobs M, Helsen MM, Takeda K, Akira S, Lubberts E, van de Loo FA and van den Berg WB: Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J Immunol. 171:6145–6153. 2003. View Article : Google Scholar : PubMed/NCBI
61	Chambard JC, Lefloch R, Pouysségur J and Lenormand P: ERK implication in cell cycle regulation. Biochim Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar
62	Krishna M and Narang H: The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci. 65:3525–3544. 2008. View Article : Google Scholar : PubMed/NCBI